【摘要】 在以知识密集、技术密集为特征的医药产业在新化学实体的发现阶段、临床前试验阶段、Ⅰ-Ⅳ期临床试验阶段都对科技情报有不同需求。本文详细分析了制药企业在不同阶段对科技信息的需求,分析了情报机构能够提供哪些精准科技信息服务,并结合典型案例,提出"增进情报机构和医药企业的相互了解,充分发挥‘广、快、精、准’情报服务、建立双方的长期合作机制、将情报服务嵌入到药物研发和审批各环节"的服务模式。更多还原

【Abstract】 During the periods of discovery of new chemical entities, the pre-clinical testing phase, the I-IV clinical trials phase, and the pharmaceutical enterprises which are knowledge and technology intended have different demands for scientific and technical information. In this paper, we analyzed the demands of pharmaceutical enterprises for science and technology information in different stages, and discussed which intelligence agencies can provide science and technology information service immediately. In addition, according to the analysis results of different cases, we put forward a service model, which was described as "to enhance the mutual understanding of the intelligence agencies and pharmaceutical companies, to provide wide, swift, precise and accurate information service, to establish long-term cooperation mechanism between the two sides, and to embed the intelligence service in the drug development and approval pipelines".更多还原